Sainte-Anne Hospital (GHU Paris Psychiatrie et Neurosciences)
Paris, 75014, France
NCT Number: NCT06661616
Electroconvulsive therapy (ECT) is the treatment of choice for drug-resistant depression (30% of patients), or when there is a short-term risk to the patient's life. Despite its robust efficacy and rapid onset of action, its use is limited both by the limited range of treatment available and by the cognitive effects sometimes induced. The present study focuses on the links between the efficacy of ECT, its cognitive effects and the formation of new neurons in the hippocampus (hippocampal neurogenesis) associated with this treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, 75014, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: After a course of ECT, up to 3 months
Centre Hospitalier St Anne
Other
Cognitive Effects Associated With Hippocampal Neurogenesis Induced by Electroconvulsive Therapy in the Treatment of Depression
Acronym: CONHECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07549581
Bipolar Disorder, Bipolar and Related Disorders
Los Alamitos, California, United States
View Trial DetailsNCT07679204
Behavior, Bipolar Disorder
Elâzığ, Turkey (Türkiye)
View Trial DetailsNCT07569198
Behavior, Behavioral Symptoms
View Trial DetailsNCT07479758
Bipolar Disorder, Bipolar and Related Disorders
Hangzhou, Zhejiang, China
View Trial Details